Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Indian Journal of Surgical Oncology
Published in: Indian Journal of Surgical Oncology 2/2021

01-06-2021 | Mastectomy | Review Article

Is Surgical Management of Primary Beneficial in Metastatic Breast Cancer??

Authors: Gaurav Patel, Bojja V Kishore Reddy, Prakash Patil

Published in: Indian Journal of Surgical Oncology | Issue 2/2021

Login to get access

Abstract

Metastatic breast cancer is not a curable disease, but women with metastatic disease are living longer. Although the relative survival has improved in recent years still patients who present with metastatic disease have a less than 30% 5-year survival. Historically, removal of the primary breast tumor has been offered to these patients only for palliation. However, there have been recent reports that removal of the primary tumor may improve survival. These are mostly retrospective studies limited by selection bias. Prospective and randomized trials have not shown a clear survival advantage. Although the definitive role of removal of the primary tumor in metastatic breast cancer is not settled, it is critical to understand the complexities of this debate in order to make further gains in breast cancer survivorship.
Literature
1.
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019 15;144(8):1941–53
2.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424CrossRef
3.
Sant M, Allemani C, Berrino F, Coleman MP, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Crosignani P, Danzon A, Federico M, Gafà L, Grosclaude P, Hédelin G, Macè-Lesech J, Garcia CM, Møller H, Paci E, Raverdy N, Tretarre B, Williams EMI, European Concerted Action on Survival and Care of Cancer Patients (EUROCARE) Working Group (2004 Feb 15) Breast carcinoma survival in Europe and the United States. Cancer. 100(4):715–722CrossRef
4.
Ly BH, Nguyen NP, Vinh-Hung V, Rapiti E, Vlastos G (2010 Feb) Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit? Breast Cancer Res Treat 119(3):537–545CrossRef
5.
Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M (2017) Estimation of the number of women living with metastatic breast Cancer in the United States. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 26(6):809–815CrossRef
6.
Ruiterkamp J, Ernst MF, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VCG, Voogd AC (2009 Nov) Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 35(11):1146–1151
7.
Thomas A, Khan SA, Chrischilles EA, Schroeder MC. Initial Surgery and Survival in Stage IV Breast Cancer in the United States, 1988–2011. JAMA Surg. 2016 01;151(5):424–31
8.
Soran A, Ozbas S, Kelsey SF, Gulluoglu BM (2009 Aug) Randomized trial comparing locoregional resection of primary tumor with no surgery in stage IV breast cancer at the presentation (protocol MF07-01): a study of Turkish Federation of the National Societies for breast diseases. Breast J 15(4):399–403CrossRef
9.
Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S (2015 Oct) Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol 16(13):1380–1388CrossRef
10.
Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E (1989 Apr 15) Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res 49(8):1996–2001PubMed
11.
Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LWMM, Hayes DF (2006 Nov 1) Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. Clin Cancer Res Off J Am Assoc Cancer Res 12(21):6403–6409CrossRef
12.
Kakarala M, Wicha MS (2008 Jun 10) Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol Off J Am Soc Clin Oncol 26(17):2813–2820CrossRef
13.
Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S (2004 Mar 15) Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res 64(6):2205–2211CrossRef
14.
Khan SA, Stewart AK, Morrow M (2002 Oct) Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 132(4):620–626 discussion 626-627
15.
Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN (2006 Jun) Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13(6):776–782CrossRef
16.
Dominici L, Najita J, Hughes M, Niland J, Marcom P, Wong Y-N, Carter B, Javid S, Edge S, Burstein H, Golshan M (2011 Sep) Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast Cancer Res Treat 129(2):459–465CrossRef
17.
Lang JE, Tereffe W, Mitchell MP, Rao R, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Hortobagyi GN, Babiera GV (2013 Jun) Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol 20(6):1893–1899CrossRef
18.
Lane WO, Thomas SM, Blitzblau RC, Plichta JK, Rosenberger LH, Fayanju OM, Hyslop T, Hwang ES, Greenup RA (2019) Surgical resection of the primary tumor in women with De novo stage IV breast Cancer: contemporary practice patterns and survival analysis. Ann Surg 269(3):537–544CrossRef
19.
Bafford AC, Burstein HJ, Barkley CR, Smith BL, Lipsitz S, Iglehart JD, Winer EP, Golshan M (2009 May) Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat 115(1):7–12CrossRef
20.
Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM (2008 May) Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg 247(5):732–738CrossRef
21.
Fields RC, Jeffe DB, Trinkaus K, Zhang Q, Arthur C, Aft R, Dietz JR, Eberlein TJ, Gillanders WE, Margenthaler JA (2007 Dec) Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 14(12):3345–3351CrossRef
22.
Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA (2007 Aug) Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol 14(8):2187–2194CrossRef
23.
Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP, Chappuis PO, Bouchardy C (2006 Jun 20) Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol Off J Am Soc Clin Oncol 24(18):2743–2749CrossRef
24.
Rao R, Feng L, Kuerer HM, Singletary SE, Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC, Babiera GV (2008 Jun) Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 15(6):1696–1702CrossRef
25.
Vohra NA, Brinkley J, Kachare S, Muzaffar M (2018) Primary tumor resection in metastatic breast cancer: a propensity-matched analysis, 1988-2011 SEER data base. Breast J 24(4):549–554CrossRef
26.
Dalberg K, Liedberg A, Johansson U, Rutqvist LE (2003 Mar) Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 29(2):143–154
27.
King TA, Lyman JP, Gonen M, Voci A, De Brot M, Boafo C, et al. Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013. J Clin Oncol Off J Am Soc Clin Oncol. 2016 10;34(20):2359–65
28.
Soran A, Ozmen V, Ozbas S, Karanlik H, Muslumanoglu M, Igci A, Canturk Z, Utkan Z, Ozaslan C, Evrensel T, Uras C, Aksaz E, Soyder A, Ugurlu U, Col C, Cabioglu N, Bozkurt B, Uzunkoy A, Koksal N, Gulluoglu BM, Unal B, Atalay C, Yıldırım E, Erdem E, Salimoglu S, Sezer A, Koyuncu A, Gurleyik G, Alagol H, Ulufi N, Berberoglu U, Dulger M, Cengiz O, Sezgin E, Johnson R (2018 Oct) Randomized trial comparing resection of primary tumor with no surgery in stage IV breast Cancer at presentation: protocol MF07-01. Ann Surg Oncol 25(11):3141–3149CrossRef
29.
Fitzal F, Bjelic-Radisic V, Knauer M, Steger G, Hubalek M, Balic M, Singer C, Bartsch R, Schrenk P, Soelkner L, Greil R, Gnant M, ABCSG. (2019) Impact of breast surgery in primary metastasized breast Cancer: outcomes of the prospective randomized phase III ABCSG-28 POSYTIVE trial. Ann Surg 269(6):1163–1169CrossRef
30.
AlJohani B, AlMalik O, Anwar E, Tulbah A, Alshabanah M, AlSyaed A, Ajarim D, ALTweigeri T (2016 Nov) Impact of surgery on survival in stage IV breast Cancer. Breast J 22(6):678–682CrossRef
31.
Harris E, Barry M, Kell MR (2013 Sep) Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival. Ann Surg Oncol 20(9):2828–2834CrossRef
32.
Somsekhar SP, Geeta K, Jain R, Nayyer R, Halder S, Malik VK, Parikh P, Aggarwal S, Koul R (2018) Practical consensus recommendations regarding role of mastectomy in metastatic breast cancer. South Asian J Cancer 7(2):79–82CrossRef
Metadata
Title
Is Surgical Management of Primary Beneficial in Metastatic Breast Cancer??
Authors
Gaurav Patel
Bojja V Kishore Reddy
Prakash Patil
Publication date
01-06-2021
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 2/2021
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-021-01329-1

Other articles of this Issue 2/2021

Indian Journal of Surgical Oncology 2/2021 Go to the issue

Images

The Contribution of Oncoplasty in the Conservative Treatment of a Large Encapsulated Papillary Carcinoma with an Invasive Component

Original Article

Small Bowel PCI Score as a Prognostic Factor of Ovarian Cancer Patients Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), a Retrospective Analysis of 130 Patients

Original Article

Primary Fibular Sarcomas: Do They Behave Differently? An Institutional Review of 14 Patients

Original Article

Presentation and Spectrum of Male Breast Cancer in a Rural Cancer Center in a Subunit of Tata Memorial Center, India

Original Article

V-Y Gluteal Advancement Fasciocutaneous Flap for Reconstruction of Perineal Defects After Surgery for Anorectal Cancers— A Single-Center Experience

Original Article

Billroth I, a Viable Alternative in Early Distal Gastric Cancers: Short-Term Results from an Indian Tertiary Care Center